2020
DOI: 10.1016/j.biomaterials.2019.119670
|View full text |Cite
|
Sign up to set email alerts
|

Construction of high quality ultrathin lanthanide oxyiodide nanosheets for enhanced CT imaging and anticancer drug delivery to efficient cancer theranostics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
19
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 36 publications
(19 citation statements)
references
References 44 publications
0
19
0
Order By: Relevance
“…In this study, a combination of X‐ray imaging/ultrasonography/computed tomography (CT) and histopathology was used to diagnose tumours 24‐26 . The samples were obtained from 42 tumour‐bearing dogs with suspected mammary tumour, including 30 (62.5%) CMTs and 12 (37.5%) skin cancers.…”
Section: Resultsmentioning
confidence: 99%
“…In this study, a combination of X‐ray imaging/ultrasonography/computed tomography (CT) and histopathology was used to diagnose tumours 24‐26 . The samples were obtained from 42 tumour‐bearing dogs with suspected mammary tumour, including 30 (62.5%) CMTs and 12 (37.5%) skin cancers.…”
Section: Resultsmentioning
confidence: 99%
“…[ 15–17 ] Moreover, these nanosystems that could provide high 3D resolution and sensitive imaging signals [e.g., X‐ray computed tomography (CT) imaging, photoacoustic (PA) imaging], and generate hyperthermia effect (temperature of higher than 42 °C) triggered by NIR‐II laser, are the desirable candidate theranostic nanoplatforms for bioimaging‐guided photonic hyperthermia. [ 18–22 ]…”
Section: Introductionmentioning
confidence: 99%
“…and sensitive imaging signals [e.g., X-ray computed tomography (CT) imaging, photoacoustic (PA) imaging], and generate hyperthermia effect (temperature of higher than 42 °C) triggered by NIR-II laser, are the desirable candidate theranostic nanoplatforms for bioimaging-guided photonic hyperthermia. [18][19][20][21][22] Previous exploration on theranostic nanosystems with both photothermal-conversion and bioimaging functions dominantly concentrated on noble-metal, [23][24][25][26] transition metal chalcogenide, [27][28][29] nanocarbons, [30,31] 2D, [32][33][34] and organic-conjugated polymeric nanosystems. [35][36][37] To date, however, owing to laborious synthesis methods, low NIR-II light absorption, and large size, the theranostic nanosystems exhibit desirable photonic hyperthermia at NIR-II biowindow are still rare, [38][39][40] which are mainly limited to several nanosystems.…”
Section: Introductionmentioning
confidence: 99%
“…along with therapeutic molecule (e. g. drugs, proteins, genes etc.). Many nanomaterials‐based theranostic agents such as metallic [1,2] (e. g. gold, silver), [2] inorganic (e. g. iron oxide, lanthanide ion doped nanoparticles), [3–11] polymeric [12] (e. g. polylactone, [13] carboxylated poly [styrene‐co‐chloromethyl styrene]‐graft‐poly ethylene glycol [14] ), carbon‐based (e. g. graphene, carbon nanotubes, carbon dot), [15,16] aggregation‐induced emission (AIE) dots [17,18] and mesoporous (e. g. mesoporous silica, mesoporous glasses) [19–21] nanomaterials have been explored. Among the above, materials possessing fluorescence as a diagnosis probe is popular since fluorescence imaging provides high sensitivity and can also be used for molecular imaging [22] .…”
Section: Introductionmentioning
confidence: 99%
“…We note that many lanthanide‐doped nanomaterials have been largely exploited as bioimaging agent but not as theranostic agents [24,25] . In this regard, few lanthanide‐based nanoparticles are explored as theranostic vehicles, for example, core‐shell structured NaLuF 4 nanorods@polydopamine, [5] Gd/Eu‐doped ZnO NPs, [6] lanthanum oxyiodide (LaOI) nanosheets, [8] polyacrylic acid (PAA)‐functionalized porous BiF 3 :Yb,Er, [9] NaLnF 4 @MOF−Ln nanocomposites, [10] zwitterionic gadolinium(III) (Gd(III))‐complexed dendrimer‐entrapped gold nanoparticles, [11] etc. Though the above reports show promising results, most of the studies are in the preliminary level and they face the following challenges:(1) do not possess targeting ability, (2) limited drug loading, (3) extensive surface chemistry to conjugate the drug, which can affect the photoluminescence properties, (4) lack of information regarding in vitro, immuno‐compatibility and in vivo toxicity, (5) lack of information regarding bio‐distribution and targeting efficiency and (6) use of high concentration for in vivo imaging.…”
Section: Introductionmentioning
confidence: 99%